• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    COMPREHENSIVE HEALTHCARE SYSTEMS ANNOUNCES APPOINTMENT OF NEW BOARD MEMBER AND CHIEF EXECUTIVE OFFICER

    1/25/22 8:00:00 AM ET
    $CERN
    $GE
    $MCK
    Managed Health Care
    Health Care
    Consumer Electronics/Appliances
    Technology
    Get the next $CERN alert in real time by email

    CALGARY, AB, Jan. 25, 2022 /CNW/ - Comprehensive Healthcare Systems Inc. (TSXV:CHS) (the "Company" or "CHS"), an industry leader in Healthcare Benefits Administration software and services, is pleased to announce the appointment of Chris Cosgrove as the Company's new President and Chief Executive Officer ("CEO") and to its board of directors effective February 1, 2022.  Mr. Cosgrove has 25 years of management and leadership experience in the healthcare technology industry and will replace CHS founder, Dr. Hassan Mohaideen, who will continue in his role as Chairman of the board of directors (the "Board") and be appointed Chief Medical Officer of the Company.

    "With a proven track record of leading and growing healthcare technology businesses, Chris is uniquely qualified to carry on our mission to streamline the way consumers navigate their healthcare," said Dr. Mohaideen. "He shares our values and vision and will continue to build upon everything that sets CHS apart. It's been an honor founding and building CHS, and I'm looking forward to working with Chris as we scale the company and grow the impact of CHS's NOVUS platform across the care continuum."

    The board of directors believe that the appointment of Mr. Cosgrove is a pivotal step towards building an institutional-grade sales focused commercial organization to ramp up sales and add new clients. A key focus area for the incoming CEO will be to target federal, state, and local governments in providing solutions to rising healthcare costs and to facilitate transparency in costs and administration. CHS's management and the board of directors believe that organic revenue growth, launching new telehealth solutions (such as for the mental health space) and focusing on strategic acquisitions will be key priority areas for CHS during 2022.

    Chris Cosgrove

    Mr. Cosgrove has been a leader and innovator in healthcare IT for over 30 years. Having worked at both Fortune 100 and early-stage companies, he has extensive experience driving company growth, product value and building high performing teams.

    Mr. Cosgrove's most recent role was Market President of Welltok's Provider Business, a leading healthcare consumer engagement company. Mr. Cosgrove and the team focused on growth and product innovation that ultimately positioned Welltok as a leader in the healthcare data analytics and patient engagement space. Prior to Welltok, he also served as EVP/GM of Vitals, a company focused on patient engagement and transparency, where he led the growth and development of new solutions into the Provider Healthcare Market. Prior to Vitals, Mr. Cosgrove held leadership positions at McKesson Provider Technologies (NYSE:MCK), Cerner Corporation (NASDAQ:CERN) and GE Healthcare (NYSE:GE).

    "With what's going on in the world today, it's never been more important to help consumers understand, navigate and manage their healthcare," Cosgrove said.  "I'm honored to be named CHS's CEO as we work to deliver innovation and value for our customers, helping to streamline the management of benefits for consumers, employers and providers. CHS has the ideal combination of compelling cloud-based offerings, with proven client deployments and a great experienced team.  I believe that CHS's core product can be the industry leader. It is flexible, cost effective, efficient and can be sold to a far wider market. The growth and enhancement of the sales capabilities will be my key priority and I'm excited about what we can accomplish, building off tremendous market growth."

    Pursuant to the employment agreement entered into between Mr. Cosgrove and the Company, CHS has granted Mr. Cosgrove options to acquire up to 500,000 common shares in the capital of CHS (each a "Share"), at an exercise price of $0.45 per Share, and vesting schedule of three years. (the "Stock Options").

    About Comprehensive Healthcare Systems Inc.

    Comprehensive Healthcare Systems Inc. is a corporation incorporated under the laws of the Province of Alberta and is the parent company of Comprehensive Healthcare Systems Inc. (Delaware). The Company is a vertically integrated software as a services (SaaS) company focused on digitizing healthcare with Telehealth and Healthcare Benefits Administration solutions, providing reliable and high-volume transaction capable systems. The Company's state of the art HPS Novus Healthcare Welfare and Benefits Administration (HWBA) SaaS platform is used by clients for all aspects of healthcare benefit administration (including insurance companies, hospitals, doctors and labor unions, through various corporation in which the majority shareholder has controlling ownership), providing healthcare administrative software, licensing and maintenance services.

    Forward-Looking Statements

    Forward-Looking Information

    This news release contains certain "forward-looking information" and "forward-looking statements" (collectively referred to as "forward-looking statements"). These forward-looking statements relate to future events or the Company's future performance. All statements other than statements of historical fact are forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "continues", "forecasts", "projects", "predicts", "intends", "anticipates" or "believes", or variations of, or the negatives of, such words and phrases, or state that certain actions, events or results "may", "could", "would", "should", "might" or "will" be taken, occur or be achieved. Particularly, information regarding our expectations of future results, targets, performance achievements, prospects or opportunities is forward-looking information. Forward-looking statements in this news release include, but may not be limited to, statements about the potential growth of the Company's product to become a future leader./

    Forward-looking statements are based on management's assumptions as at the date the forward-looking statements are provided, including assumptions regarding: the Company's management ability to execute its business strategy. Though management believes that its assumptions are reasonable in the circumstances, forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results, performance, or achievements to differ materially from all or any of the future results, performance or achievements expressed or implied by forward-looking statements. Risk factors that could cause the Company's actual results, performance, or achievements to differ from the forward-looking statements in this news release include but may not be limited to: the inability of the Company's management to execute its business strategy, adverse or unexpected changes to regulatory regimes related to the medical industry, and general market and economic risks. Accordingly, readers should not place undue reliance on forward-looking statements.

    The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.

    Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

    SOURCE Comprehensive Healthcare Systems Inc.

    Cision View original content: http://www.newswire.ca/en/releases/archive/January2022/25/c3409.html

    Get the next $CERN alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CERN
    $GE
    $MCK

    CompanyDatePrice TargetRatingAnalyst
    GE Aerospace
    $GE
    5/19/2025Buy → Neutral
    Northcoast
    GE Aerospace
    $GE
    4/9/2025$205.00Neutral → Buy
    Northcoast
    GE Aerospace
    $GE
    2/18/2025$250.00Buy
    Redburn Atlantic
    GE Aerospace
    $GE
    1/7/2025Neutral
    Northcoast
    McKesson Corporation
    $MCK
    12/4/2024$630.00Neutral
    Mizuho
    McKesson Corporation
    $MCK
    11/7/2024$531.00 → $688.00Neutral → Outperform
    Robert W. Baird
    GE Aerospace
    $GE
    10/14/2024$201.00 → $225.00Outperform
    Bernstein
    McKesson Corporation
    $MCK
    9/24/2024$603.00 → $531.00Outperform → Neutral
    Robert W. Baird
    More analyst ratings

    $CERN
    $GE
    $MCK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    GE Aerospace downgraded by Northcoast

    Northcoast downgraded GE Aerospace from Buy to Neutral

    5/19/25 8:49:04 AM ET
    $GE
    Consumer Electronics/Appliances
    Technology

    GE Aerospace upgraded by Northcoast with a new price target

    Northcoast upgraded GE Aerospace from Neutral to Buy and set a new price target of $205.00

    4/9/25 8:08:47 AM ET
    $GE
    Consumer Electronics/Appliances
    Technology

    Redburn Atlantic initiated coverage on GE Aerospace with a new price target

    Redburn Atlantic initiated coverage of GE Aerospace with a rating of Buy and set a new price target of $250.00

    2/18/25 7:08:41 AM ET
    $GE
    Consumer Electronics/Appliances
    Technology

    $CERN
    $GE
    $MCK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Reagan Foundation and GE Aerospace Announce 15th Class of GE-Reagan Foundation Scholarship Program Recipients to Receive $40,000 Each

    Nearly $10 Million Awarded to More Than 236 Students Since 2011 SIMI VALLEY, Calif., Aug. 12, 2025 /PRNewswire/ -- Today the Ronald Reagan Presidential Foundation and Institute, in partnership with GE Aerospace, recognized this year's class of GE-Reagan Foundation Scholarship Program recipients. Selected for their exemplary leadership, drive, integrity, and citizenship, the 2025 Scholars are: Nachammai Annamalai Mooresville, NC Princeton University Grant Feldman Freehold, NJ University of Florida Alex Goetsch Cedar Falls, IA University of North Dakota Liliana Katz-Hollander Kensington, MD Smith College Logan Lee Honolulu, HI Yale University Tyler Ly Danville, CA University of California, Be

    8/12/25 1:32:00 PM ET
    $GE
    Consumer Electronics/Appliances
    Technology

    McKesson Corporation Reports Fiscal 2026 First Quarter Results and Raises Full Year Adjusted EPS Guidance

    McKesson Corporation (NYSE:MCK) has released its fiscal 2026 first quarter financial results. Results can be accessed on McKesson's Investor Relations website at investor.mckesson.com/financials/quarterly-results. As previously announced, the company will host a live webcast of the earnings conference call for investors today, Wednesday, August 6 at 4:30 PM ET to review its financial results. The audio webcast of the conference call will be available live and archived on McKesson's Investor Relations website, along with the company's earnings press release, financial tables, and slide presentation. Additional information about upcoming events for the investor community can be found at inv

    8/6/25 4:10:00 PM ET
    $MCK
    Other Pharmaceuticals
    Health Care

    Cathay Pacific Signs Agreement for More GE Aerospace Engines to Power 777-9s

    CINCINNATI , Aug. 6, 2025 /PRNewswire/ -- GE Aerospace (NYSE:GE) announced today that Cathay Pacific has committed to purchasing GE9X engines to power 14 additional Boeing 777-9 aircraft, bringing the airline's total commitment to 35 GE9X powered 777-9s.  The deal also includes a service agreement to cover the maintenance, repair, and overhaul of the GE9X engines.  "Cathay Pacific was the first customer in the Asia-Pacific region to select the new GE9X engine and we're honored they continue to place their confidence in our products and services," said Mahendra Nair, Group Vice

    8/6/25 1:18:00 AM ET
    $GE
    Consumer Electronics/Appliances
    Technology

    $CERN
    $GE
    $MCK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, Controller & CAO Rutledge Napoleon B Jr sold $218,347 worth of shares (329 units at $663.67), decreasing direct ownership by 33% to 657 units (SEC Form 4)

    4 - MCKESSON CORP (0000927653) (Issuer)

    8/11/25 4:52:21 PM ET
    $MCK
    Other Pharmaceuticals
    Health Care

    Senior Vice President Ali Mohamed exercised 1,517 shares at a strike of $146.33 and sold $407,755 worth of shares (1,517 units at $268.79) (SEC Form 4)

    4 - GENERAL ELECTRIC CO (0000040545) (Issuer)

    8/6/25 4:07:50 PM ET
    $GE
    Consumer Electronics/Appliances
    Technology

    SEC Form 4 filed by Director Gerberding Julie L.

    4 - MCKESSON CORP (0000927653) (Issuer)

    7/31/25 6:38:18 PM ET
    $MCK
    Other Pharmaceuticals
    Health Care

    $CERN
    $GE
    $MCK
    SEC Filings

    View All

    SEC Form 10-Q filed by McKesson Corporation

    10-Q - MCKESSON CORP (0000927653) (Filer)

    8/6/25 5:30:47 PM ET
    $MCK
    Other Pharmaceuticals
    Health Care

    McKesson Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - MCKESSON CORP (0000927653) (Filer)

    8/6/25 4:06:31 PM ET
    $MCK
    Other Pharmaceuticals
    Health Care

    SEC Form 144 filed by GE Aerospace

    144 - GENERAL ELECTRIC CO (0000040545) (Subject)

    8/5/25 5:07:46 PM ET
    $GE
    Consumer Electronics/Appliances
    Technology

    $CERN
    $GE
    $MCK
    Leadership Updates

    Live Leadership Updates

    View All

    Dentsply Sirona Appoints Michael Barber and Daniel Scavilla as New Board Members

    CHARLOTTE, N.C., Feb. 06, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that Michael J. Barber and Daniel T. Scavilla have been appointed to its Board of Directors (the "Board"), effective February 5, 2025. Mr. Barber brings over 40 years of experience in product management and innovation, including executive leadership roles at GE, where he was responsible for the transformation of the company's digital X-Ray program. Mr. Scavilla, currently CEO of Globus Medical, is a seasoned executive with a deep skillset in commercial deployment and business integration, having successfully led the merger of Globus and NuVasive. Mr. B

    2/6/25 8:30:00 AM ET
    $EXAS
    $GE
    $GMED
    Medical Specialities
    Health Care
    Consumer Electronics/Appliances
    Technology

    McKesson Signs Agreement to Acquire Controlling Interest in Florida Cancer Specialists & Research Institute's Core Ventures

    Acquisition enhances McKesson's integrated oncology platform; Florida Cancer Specialists & Research Institute to join The US Oncology Network McKesson Corporation (NYSE:MCK) announced today that it signed a definitive agreement to acquire a controlling interest in Community Oncology Revitalization Enterprise Ventures, LLC (Core Ventures). Core Ventures, a business and administrative services organization, was established by Florida Cancer Specialists & Research Institute, LLC (FCS), a leading physician-owned community oncology practice. FCS physicians will continue to retain a minority interest in Core Ventures. McKesson will purchase its controlling interest for approximately $2.49 bil

    8/26/24 8:00:00 AM ET
    $MCK
    Other Pharmaceuticals
    Health Care

    MultiPlan Announces CFO Transition

    MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions to the U.S. healthcare industry, announced today its CFO transition plan and named Doug Garis as EVP and CFO, effective August 5, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240731993142/en/Doug Garis named EVP and CFO of MultiPlan (Photo: Business Wire) Jim Head, who has served as EVP and CFO of MultiPlan since November 2021, will transition to a Strategic Advisor role to the Company through the end of the

    8/1/24 6:00:00 AM ET
    $DOOR
    $MPLN
    $ORCL
    Forest Products
    Basic Materials
    Business Services
    Consumer Discretionary

    $CERN
    $GE
    $MCK
    Financials

    Live finance-specific insights

    View All

    McKesson Corporation Reports Fiscal 2026 First Quarter Results and Raises Full Year Adjusted EPS Guidance

    McKesson Corporation (NYSE:MCK) has released its fiscal 2026 first quarter financial results. Results can be accessed on McKesson's Investor Relations website at investor.mckesson.com/financials/quarterly-results. As previously announced, the company will host a live webcast of the earnings conference call for investors today, Wednesday, August 6 at 4:30 PM ET to review its financial results. The audio webcast of the conference call will be available live and archived on McKesson's Investor Relations website, along with the company's earnings press release, financial tables, and slide presentation. Additional information about upcoming events for the investor community can be found at inv

    8/6/25 4:10:00 PM ET
    $MCK
    Other Pharmaceuticals
    Health Care

    McKesson Corporation Raises Quarterly Dividend by 15% to $0.82 Per Share

    The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of $0.82 per share of common stock, a 15% increase from $0.71 per share in the prior quarter. The dividend will be payable on October 1, 2025, to stockholders of record on September 2, 2025. "McKesson continues our long-standing track record of returning capital to shareholders, marking our ninth consecutive annual dividend increase," said Brian Tyler, chief executive officer. "These actions reflect our confidence in the strength of our business and reinforces our commitment to delivering long-term value to shareholders." About McKesson Corporation McKesson Corporation is a diversified heal

    7/30/25 8:00:00 AM ET
    $MCK
    Other Pharmaceuticals
    Health Care

    GE Aerospace Board of Directors Authorizes Regular Quarterly Dividend

    The Board of Directors of GE Aerospace (NYSE:GE) today declared a $0.36 per share dividend on the outstanding common stock of the Company. The dividend is payable July 25, 2025, to shareholders of record at the close of business on July 7, 2025. The ex-dividend date is July 7, 2025. About GE Aerospace GE Aerospace (NYSE:GE) is a global aerospace propulsion, services, and systems leader with an installed base of approximately 45,000 commercial and 25,000 military aircraft engines. With a global team of approximately 53,000 employees building on more than a century of innovation and learning, GE Aerospace is committed to inventing the future of flight, lifting people up, and bringing them

    6/27/25 11:44:00 AM ET
    $GE
    Consumer Electronics/Appliances
    Technology

    $CERN
    $GE
    $MCK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by GE Aerospace

    SC 13G/A - GENERAL ELECTRIC CO (0000040545) (Subject)

    11/12/24 12:54:20 PM ET
    $GE
    Consumer Electronics/Appliances
    Technology

    SEC Form SC 13G/A filed by McKesson Corporation (Amendment)

    SC 13G/A - MCKESSON CORP (0000927653) (Subject)

    2/13/24 5:09:38 PM ET
    $MCK
    Other Pharmaceuticals
    Health Care

    SEC Form SC 13G/A filed by General Electric Company (Amendment)

    SC 13G/A - GENERAL ELECTRIC CO (0000040545) (Subject)

    2/13/24 4:55:49 PM ET
    $GE
    Consumer Electronics/Appliances
    Technology